Page 1 of Clinical Trials for acarbose treatment, 44 Total Matches
- 1CompletedLast Updated: January 5, 2012Condition(s): PCO
- 2Not yet recruitingLast Updated: March 15, 2011Condition(s): Type 2 Diabetes Mellitus
- 3CompletedLast Updated: May 3, 2012Condition(s): Diabetes Mellitus
- 4CompletedLast Updated: March 13, 2012Condition(s): Diabetes Mellitus, Type 2
- 5CompletedLast Updated: March 5, 2008Condition(s): Metabolic Syndrome
- 6CompletedLast Updated: November 4, 2010Condition(s): Type 2 Diabetes; Endothelial Dysfunction
- 7Active, not recruitingLast Updated: April 13, 2012Condition(s): Diabetes Mellitus
- 8CompletedLast Updated: March 5, 2012Condition(s): Type 2 Diabetes
- 9RecruitingLast Updated: May 12, 2008Condition(s): Non-Alcoholic Fatty Liver Disease
- 10CompletedLast Updated: January 18, 2012Condition(s): Diabetes Mellitus
- 11RecruitingLast Updated: November 19, 2010Condition(s): The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg; Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in; Subjects With Type 2 Diabetes Mellitus.
- 12CompletedLast Updated: December 23, 2010Condition(s): Diabetes Mellitus
- 13Not yet recruitingLast Updated: December 11, 2011Condition(s): Type-II Diabetes Mellitus
- 14RecruitingLast Updated: January 24, 2011Condition(s): Type 2 Diabetes Mellitus
- 15RecruitingLast Updated: May 10, 2012Condition(s): Autonomic Failure; Orthostatic Hypotension
- 16CompletedEfficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesLast Updated: May 4, 2012Condition(s): Diabetes Mellitus, Type 2
- 17RecruitingLast Updated: December 3, 2009Condition(s): Chronic Hepatitis C
- 18CompletedLast Updated: April 10, 2008Condition(s): Type 2 Diabetes Mellitus; Subclinical Inflammation
- 19CompletedLast Updated: March 21, 2008Condition(s): Diabetes Mellitus; Type 2 Diabetes Mellitus
- 20RecruitingLast Updated: February 17, 2009Condition(s): Pediatric Obesity; Insulin Resistance; Impaired Glucose Tolerance; Cardiovascular Disease
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=acarbose+treatment
